Tissue factor inhibitor

This page covers all Tissue factor inhibitor drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Tissue factor.

Targets

Tissue factor

Phase 2 pipeline (1)

• AMG 853 · Amgen · Cardiovascular
  AMG 853 is a recombinant, humanized monoclonal antibody that targets and neutralizes tissue factor.